(Q34469990)

2 August 2017

1 reference

title

A mechanistic approach to antiepileptic drug interactions (English)

1 reference

2 August 2017

G D Anderson

1

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 May 1998

1 reference

Annals of Pharmacotherapy

2 August 2017

published in

1 reference

2 August 2017

volume

32

1 reference

2 August 2017

issue

5

1 reference

2 August 2017

page(s)

554-563

1 reference

Pharmacokinetic drug interactions with phenytoin (Part I).

2 August 2017

cites work

1 reference

Clinically significant pharmacokinetic drug interactions with carbamazepine. An update

21 January 2018

1 reference

A comparative study of the relative enzyme inducing properties of anticonvulsant drugs in epileptic patients

21 January 2018

1 reference

Effect of the removal of individual antiepileptic drugs on antipyrine kinetics, in patients taking polytherapy

21 January 2018

1 reference

Inhibitors of Cytochrome P-450s and their mechanism of action

21 January 2018

1 reference

The human hepatic cytochromes P450 involved in drug metabolism

21 January 2018

1 reference

Acute phenytoin toxicity followed by seizure breakthrough from a ticlopidine-phenytoin interaction

21 January 2018

1 reference

Pharmacokinetic interactions with felbamate. In vitro-in vivo correlation

21 January 2018

1 reference

In vivo evidence that ethosuximide is a substrate for cytochrome P450IIIA

21 January 2018

1 reference

Cytochrome P450 isozymes and antiepileptic drug interactions

21 January 2018

1 reference

Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions

21 January 2018

1 reference

Inhibition of phenobarbitone N-glucosidation by valproate

21 January 2018

1 reference

Bidirectional interaction of valproate and lamotrigine in healthy subjects.

21 January 2018

1 reference

Gabapentin: a new agent for the management of epilepsy

21 January 2018

1 reference

Pharmacokinetics and interaction profile of topiramate: review and comparison with other newer antiepileptic drugs

21 January 2018

1 reference

Vigabatrin. Clinical pharmacokinetics

21 January 2018

1 reference

Unplanned pregnancy in an epileptic

21 January 2018

1 reference

Letter: Anti-epileptic drugs and failure of oral contraceptives.

21 January 2018

1 reference

Interaction between phenobarbital and diphenylhydantoin in animals and in epileptic patients.

21 January 2018

1 reference

Therapeutic and pharmacokinetic effects of increasing phenytoin in chronic epileptics on multiple drug therapy

21 January 2018

1 reference

Fatal phenytoin warfarin interaction

21 January 2018

1 reference

Drug interactions with valproic acid

21 January 2018

1 reference

Predicting unbound phenytoin concentrations in patients receiving valproic acid: a comparison of two prediction methods

21 January 2018

1 reference

Pharmacokinetics of carbamazepine in normal humans after single and repeated oral doses

21 January 2018

1 reference

Erythromycin-induced carbamazepine toxicity: a continuing problem

21 January 2018

1 reference

Interactions between calcium channel blockers and the anticonvulsants carbamazepine and phenytoin

21 January 2018

1 reference

Calcium channel blockers as inhibitors of drug metabolism

21 January 2018

1 reference

Pharmacokinetic interaction between zidovudine and valproic acid in patients infected with human immunodeficiency virus

21 January 2018

1 reference

Ethosuximide kinetics: possible interaction with valproic acid

21 January 2018

1 reference

Pharmacokinetic interactions of the new antiepileptic drugs

21 January 2018

1 reference

Lamotrigine. An update of its pharmacology and therapeutic use in epilepsy

21 January 2018

1 reference

Vigabatrin-induced decrease in serum phenytoin concentration does not involve a change in phenytoin bioavailability.

21 January 2018

1 reference

Valproic acid-induced carbamazepine-10,11-epoxide toxicity in children and adolescents

21 January 2018

1 reference

Tiagabine pharmacology in profile

21 January 2018

1 reference

Human liver carbamazepine metabolism. Role of CYP3A4 and CYP2C8 in 10,11-epoxide formation

21 January 2018

1 reference

Comparison of the steady-state pharmacokinetics of topiramate and valproate in patients with epilepsy during monotherapy and concomitant therapy

21 January 2018

1 reference

Warfarin and Phenytoin Interaction

21 January 2018

1 reference

Carbamazepine increases phenytoin serum concentration and reduces phenytoin clearance

21 January 2018

1 reference

Time course of phenobarbital and cimetidine mediated changes in hepatic drug metabolism

21 January 2018

1 reference

Interactions between prim done, carbamazepine, and nicotinamide

21 January 2018

1 reference

Rapid reversibility of autoinduction of carbamazepine metabolism after temporary discontinuation

21 January 2018

1 reference

Anticonvulsant cotreatment may increase toxic metabolites of antidepressants and other psychotropic drugs.

21 January 2018

1 reference

Evaluation of the effect of fluoxetine on the formation of carbamazepine epoxide

21 January 2018

1 reference

Increased carbamazepine plasma concentrations after fluoxetine coadministration

21 January 2018

1 reference

Variability and clinical relevance of the interaction between sodium valproate and carbamazepine in epileptic patients

21 January 2018

1 reference

Carbamazepine--erythromycin interaction leading to carbamazepine toxicity in four epileptic children

21 January 2018

1 reference

Clarithromycin-carbamazepine interaction: a case report

21 January 2018

1 reference

Interaction between carbamazepine and triacetyloleandomycin

21 January 2018

1 reference

Interaction of propoxyphene with carbamazepine

21 January 2018

1 reference

The lack of effect of sodium valproate on the pharmacokinetics of oral contraceptive steroids

21 January 2018

1 reference

Lorazepam-valproate interaction: studies in normal subjects and isolated perfused rat liver

21 January 2018

1 reference

The effect of felbamate on valproic acid disposition

21 January 2018

1 reference

Effect of felbamate on valproic acid disposition in healthy volunteers: inhibition of beta-oxidation

21 January 2018

1 reference

Influence of ethosuximide on valproic acid serum concentrations

21 January 2018

1 reference

Ethosuximide intoxication caused by interaction with isoniazid

21 January 2018

1 reference

Lamotrigine-induced carbamazepine toxicity: an interaction with carbamazepine-10,11 -epoxide

21 January 2018

1 reference

Single dose pharmacokinetics of carbamazepine-10,11-epoxide in patients on lamotrigine monotherapy

21 January 2018

1 reference

Kinetic effects of multiple oral doses of acetaminophen on a single oral dose of lamotrigine

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.17332

1 reference

2 August 2017

1 reference